In this episode of the Odd Lots podcast, hosts Tracy Alloway and Joe Weisenthal interview D.A. Wallach, a biotech investor and former lead singer of Chester French, about the world of biotech investing. Wallach discusses his career transition, the unique challenges of biotech investing compared to tech, including low success rates and long development timelines, and the importance of experience in the field. The conversation covers sourcing investments, the role of AI in drug development, regulatory hurdles, competition with China, and the financial incentives driving U.S. drug pricing. Wallach also shares his thoughts on the public's trust in science and the role of patient autonomy in medical decisions, and at the end, he performs a short song for the hosts.
Sign in to continue reading, translating and more.
Continue
